Form 4: Profusa Director Awarded 274,660 Stock Options

Sentiment:

Insider Transaction Report


Profusa Director Rajesh Asarpota received 274,660 stock options with an exercise price of $0.35, vesting over one to three years.

Summary

  • Rajesh Asarpota, a Director of Profusa, Inc. (PFSA), acquired a total of 274,660 stock options.
  • The options have an exercise price of $0.35 per share.
  • This total includes an inaugural director award of 221,794 options and an annual director award of 52,866 options.
  • The inaugural award vests in three equal annual increments over a period of three years from the closing of the business combination between Profusa, Inc. and NorthView Acquisition Corp.
  • The annual award vests on the first anniversary of the closing of the business combination.
  • All awarded options have an expiration date of January 26, 2036.

Sentiment

Score: 6

Explanation: The filing reports a standard insider transaction (equity award) which is generally neutral but can be seen as slightly positive due to increased alignment of director interests with shareholders.

Positives

  • The award of stock options to Director Rajesh Asarpota aligns his interests with long-term shareholder value.
  • Equity compensation is a standard practice to incentivize directors and retain talent.

Future Outlook

The vesting schedules for the stock options indicate future equity ownership for the director, with the inaugural award vesting over three years and the annual award vesting on the first anniversary of the business combination's closing.

Industry Context

The granting of stock options to directors is a common practice across various industries to provide long-term incentives and align the interests of board members with those of shareholders. This transaction is consistent with typical corporate governance and compensation structures for publicly traded companies.

Comparison to Industry Standards

  • The structure of director equity awards, including inaugural and annual grants with multi-year vesting, is a common compensation mechanism seen in many technology and biotech companies, similar to practices at firms like Medtronic or Dexcom, which use equity to incentivize leadership.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationAward of stock options to Director Rajesh Asarpota as part of inaugural and annual director compensation.01/26/2026Aligns director's interests with long-term shareholder value through equity ownership, reinforcing governance best practices for executive incentives.

Related Party Transactions

  • Award of 274,660 stock options to Director Rajesh Asarpota, which constitutes compensation to a related party.

Stakeholder Impact

  • Shareholders: The award of options to a director can be viewed positively as it aligns the director's financial interests with the company's long-term performance, potentially leading to better decision-making that benefits shareholder value.

Next Steps

  • Vesting of the inaugural director award in three equal annual increments over three years from the closing of the business combination.
  • Vesting of the annual director award on the first anniversary of the closing of the business combination.

Key Dates

DateDescription
01/26/2026Transaction date for the acquisition of stock options by Director Rajesh Asarpota.
01/26/2026Date exercisable for the stock options.
01/26/2036Expiration date for all awarded stock options.

Keywords

Profusa, PFSA, stock options, director compensation, equity award, insider transaction, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.